KPIs & Operating Metrics(New)
Growth Metrics

Hologic (HOLX) Current Deferred Revenue (2016 - 2025)

Hologic's Current Deferred Revenue history spans 17 years, with the latest figure at $170.9 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 8.85% year-over-year to $170.9 million; the TTM value through Dec 2025 reached $170.9 million, down 8.85%, while the annual FY2025 figure was $199.7 million, 6.2% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $170.9 million at Hologic, down from $199.7 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $232.9 million in Q3 2023 and bottomed at $170.9 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $199.6 million (2022), against an average of $203.1 million.
  • The largest annual shift saw Current Deferred Revenue increased 21.7% in 2021 before it decreased 9.76% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $192.1 million in 2021, then decreased by 0.26% to $191.6 million in 2022, then fell by 0.52% to $190.6 million in 2023, then dropped by 1.63% to $187.5 million in 2024, then dropped by 8.85% to $170.9 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Current Deferred Revenue are $170.9 million (Q4 2025), $199.7 million (Q3 2025), and $212.7 million (Q2 2025).